MedTrace Logo

Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy

NCT02908724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2018-10-16

No results posted yet for this study

Summary

The purpose of this study was to assess the progression of cardiac involvement in adult patients with Fabry Disease (FD), in the unique Danish Fabry cohort and comparing those FD patients receiving primary therapy vs. those that did not.

The hypothesis is, that we will not be able to see a significant positive difference in cardiac involvement in those FD patient who received FD specific therapy vs. those that did not.

Conditions

Sponsors & Collaborators

  • Ulla Feldt-Rasmussen

    lead OTHER

Principal Investigators

  • Ulla Feldt-Rasmussen, MD,DMSc,Prof · Department of Medical Endocrinology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2014-11-30
Completion
2016-02-09

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02908724 on ClinicalTrials.gov